A Phase 1b, Double-Blind, Placebo-Controlled, First-in-Human Study to Evaluate Safety, Tolerability and Pharmacokinetics of a Two-Week Oral Treatment With STP1 in a Subgroup of Patients With Autism Spectrum Disorder
The main purpose of this study is to evaluate safety and tolerability in a subgroup of patients with Autism Spectrum Disorder (ASD). In addition, Pharmacokinetics and Pharmacodynamics, as well as efficacy of STP1 are being explored.
100 项与 MIF x NKCC1 x NKCC2 x PDE10A x PDE11A x PDE3 x PDE4 x SLC12A4 x TLR4 相关的临床结果
100 项与 MIF x NKCC1 x NKCC2 x PDE10A x PDE11A x PDE3 x PDE4 x SLC12A4 x TLR4 相关的转化医学
0 项与 MIF x NKCC1 x NKCC2 x PDE10A x PDE11A x PDE3 x PDE4 x SLC12A4 x TLR4 相关的专利(医药)